Novartis Ag (NVS) EBITDA Margin (2009 - 2026)
Novartis Ag (NVS) recorded EBITDA Margin of 41.51% in Q1 2026, down 2.76 percentage points from 44.27% a year earlier.
Powered by 
Analysis
Novartis Ag (NVS) EBITDA Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Novartis Ag's EBITDA Margin came in at 38.00% as of Mar 31, 2026, up 0.12 percentage points year-over-year; for FY2022, it came in at -128.81%, up 7.09 percentage points from FY2021.
- Annual EBITDA Margin has a five-year change of -164.28 percentage points (FY2017 to FY2022).
- Across earlier years, EBITDA Margin came in at -135.90% in FY2021.
- The Q1 2026 figure is the lowest quarterly EBITDA Margin since Q1 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn | 22.73% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 41.51% |
| Mar 31, 2025 | 44.27% |
| Mar 31, 2024 | 39.86% |
| Mar 31, 2023 | 43.17% |
| Mar 31, 2022 | 34.79% |
| Mar 31, 2021 | 32.32% |
| Mar 31, 2020 | 34.14% |
| Mar 31, 2019 | 33.11% |
| Mar 31, 2018 | 30.21% |
| Dec 31, 2017 | 61.32% |
| Sep 30, 2017 | 30.90% |
| Jun 30, 2017 | 29.68% |
| Mar 31, 2017 | 32.05% |
| Dec 31, 2016 | 26.68% |
| Sep 30, 2016 | 31.15% |
| Jun 30, 2016 | 28.54% |
| Mar 31, 2016 | 32.93% |
| Dec 31, 2015 | 24.81% |
| Sep 30, 2015 | 29.26% |
| Jun 30, 2015 | 29.86% |
API Access
Novartis Ag EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();